KALV
KalVista Pharmaceuticals, Inc. · Healthcare
CEO Thomas Andrew Crockett sold $51K of KalVista Pharmaceuticals, Inc.
Sold$51,322
$7.66Price
6,700Shares
−5%Stake
What KALV did after the filing
- The stock from Thu, Feb 23 close, $7.88
- +1.3%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Apr 6 close.
Traded Fri, Feb 17. Filed Thu, Feb 23, 12:40 PM ET, during the session. Returns use the Feb 23 close and the Apr 6 close. Not investment advice.